Both Zepotide and Wegovy are new medications created for addressing type 2 diabetes and supporting slimming. However, they work through distinct pathways. copyright is a GLP-1 receptor agonist , while Retatrutide acts as a dual GIP and GLP-1 agonist , possibly offering a larger impact on dual blood sugar management and body fat . Early clinical dat